Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Make your likes visible on Facebook?

Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.

No, thanks

Pharmaceutical Industry Analysis

No description
by

vikas Agrawal

on 8 February 2012

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Pharmaceutical Industry Analysis

Scenario Analysis (cc) image by nuonsolarteam on Flickr Scenario 1 Innovation
Reliability
Trust Recommendation
Innovative Process Improvements to reduce the cost Research Funds
Public and Private patnership Let’s
make
some
money Threats
Generic Drug Market
Low cost models
High Treatment and High Innovation Scenario 2 Scenario 3 Scenario 4 Hostility towards drug companies Access to Brains and Capital

Focus on building trust Lawsuits, Public Campaigns
Goodbye Relation between universities and companies Low Treatment and Low Innovation Integration
Balance Recommendation
Optimization of dosage
New technologies to increase efficiency
and Safty Threats
Consumer confidence Low
New ventures from universities

Come on People Focus on performance improvement Low Treatment and High Innovation Braaains High Treatment and Low Innovation Healthcare Ecosystem and Pharmaceutical
Scenario Analysis Team Members Olabanji Bamgbade
Emeka Odenigbo
John Cranshaw
Vikas Agrawal Thank You Lack of technical knowledge Recommendation
Brains- Problem Solving, curosity

Focus on niche markets to add value Safety and efficiency

Quality of innovation--
Search for alternatives Search for alternatives Alternative treatments Threats
Generic Drug Market

Cost of production Recommendation

Quality

Innovation

State of Art technologies
Metabolic Network Profiling
RNA interference
Manage Research Develop Product Manage Supply Chain Perform Managed Healthcare service Manufacture Product Perform Marketing and Sales A typical Value chain for a pharmaceutical company Recommendations Government Grants Protect intellectual property Value Chain Innovation
Social Awareness
Strong bond with universities Acceptance of pharma treatment Education Metabolic Network Profiling RNA inference Outsource to smaller pharma companies Regulatory Section Market Section Competition 3 D Analysis Strategic Stake Holder Analysis Pharmaceutical Group Global R&D One of the largest pharmaceutical companies in the world

5 of world’s top-selling medicines
9 are #1 in their therapeutic class in the U.S. market
8 of the medicines will earn revenues of more than $1 billion globally Pfizer
Full transcript